DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Strosberg J, Mizuno N, Doi T. et al.
Efficacy and safety of pembrolizumab in previously treated advanced neuroendocrine tumors: results from the phase II KEYNOTE-158 study.
Clin Cancer Res 2020;
26 (09) 2124-2130
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.